David Shapiro, CMO and EVP - Development at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 3,130 shares at $106.01 ($332K) on 2017-01-09, disclosed to the SEC on 2017-01-11.
Seasonal sale ($332k) by CMO and EVP - Development — this insider has traded ICPT in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.01 | 1,565 | $166K | 50.0% |
| 2 | $106.01 | 1,565 | $166K | 50.0% |
| Total | $106.01 avg | 3,130 | $332K | 100% |
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |